Read the latest epilepsy news from Epilepsy Society.
Clinically trialled medicinal cannabis product could be given final approval in two months
30 July 2019
Epidyolex, an oral solution of cannabidiol, has been recommended for approval for use as an add-on therapy for seizures.
Actor Idris Elba comes to aid of woman having a seizure
29 July 2019
Epilepsy Society has hailed actor Idris Elba a superhero after he stopped his new play, Tree - mid-performance - to help a woman in the audience who was having a...
More batches of Vimpat 100mg tablets recalled by MHRA
26 July 2019
More batches of the epilepsy medication Vimpat (lacosamide) 100mg tablets have been recalled by the Medicines and Healthcare products Regulatory Agency (MHRA).
Epilim Chronosphere 1000mg modified release temporarily out of stock
12 July 2019
Sanofi has informed us that Epilim Chronosphere 1000mg Modified Release is temporarily out of stock in the UK.
Last chance for school children to design a seizure first aid poster and win £125
12 July 2019
Primary school pupils across the UK to are being given a chance to design a seizure first aid poster to raise awareness of epilepsy.
Invite your local MP to All Party Parliamentary Group on Epilepsy meeting to discuss Brexit
4 July 2019
The All Party Parliamentary Group on Epilepsy is holding a meeting on 23 July about the effect of Brexit on epilepsy.
Epilepsy Society submits response to Government's Online Harms White Paper
3 July 2019
Epilepsy Society has submitted its response to the Online Harms White Paper, calling on the Government to include safeguarding measures for people with photosensitive...
Young woman experiences the world of politics through our 'Me and My Shadow' scheme
2 July 2019
Budding politician Sydney Joyce, recently shadowed Paula Sherriff MP as part of our 'Me and My Shadow' scheme.
World Health Organization calls for action to reduce issues around epilepsy worldwide
1 July 2019
A new report released by the World Health Organisation (WHO) calls for action to improve healthcare and reduce stigma and discrimination around epilepsy.